The US Food and Drug Administration (FDA) approved 2 medications to treat Ebola virus disease caused by Zaire Ebola virus in adults and children: a combination of three monoclonal antibodies (atoltivimab / maftivimab / odesivimab) and a single monoclonal antibody (ansuvimab).